Cargando…

Gene-Related Response of Basal Cell Carcinoma to Biologic Treatment with Vismodegib

We aimed to characterise the response of locally advanced basal cell carcinoma (BCC) to systemic treatment with Vismodegib, a Hedgehog pathway inhibitor, by changes in the expression levels of Hedgehog pathway genes. Data were collected prospectively on 12 patients treated systemically for locally a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sternfeld, Amir, Rosenwasser-Weiss, Shirel, Ben-Yehuda, Gur, Shefer, Hila Kreizman, Friedman-Gohas, Moran, Yassur, Iftach, Tauber, Gil, Bejar, Jacob, Olshinka, Asaf, Vardizer, Yoav, Ad El, Dean, Goldenberg-Cohen, Nitza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985141/ https://www.ncbi.nlm.nih.gov/pubmed/31988301 http://dx.doi.org/10.1038/s41598-020-58117-0

Ejemplares similares

Diffusion Reflection Measurements of Antibodies Conjugated to Gold Nanoparticles as a Method to Identify Cutaneous Squamous Cell Carcinoma Borders
por: Olshinka, Asaf, et al.
Publicado: (2020)

Neuroprotective Effect of Azithromycin Following Induction of Optic Nerve Crush in Wild Type and Immunodeficient Mice
por: Zloto, Ofira, et al.
Publicado: (2022)

Abstract: 8.30 Identifying The Border Of Cutaneous Squamous Cell Carcinoma By Targeted Egfr Antibodies Conjugated To Gold Nanoparticles
por: Olshinka, Asaf, et al.
Publicado: (2017)

Azithromycin and Sildenafil May Have Protective Effects on Retinal Ganglion Cells via Different Pathways: Study in a Rodent Microbead Model
por: Sela, Tal Corina, et al.
Publicado: (2023)

Trace Elements in Tears: Comparison of Rural and Urban Populations Using Particle Induced X-ray Emission
por: Girshevitz, Olga, et al.
Publicado: (2022)

Vismodegib: the Proof of Concept in Basal Cell Carcinoma
por: Berrada, Narjiss, et al.
Publicado: (2014)

Distribution of estrogen and progesterone receptors isoforms in endometrial cancer
por: Kreizman-Shefer, Hila, et al.
Publicado: (2014)

Preoperative Visual Loss is the Main Cause of Irreversible Poor Vision in Children with a Brain Tumor
por: Goldenberg-Cohen, Nitza, et al.
Publicado: (2011)

Treatment of periocular basal cell carcinoma with neoadjuvant vismodegib
por: Su, Maxwell G., et al.
Publicado: (2020)

Treatment of Locally Advanced Basal Cell Carcinomas with Vismodegib
por: Mastronardi, Luis, et al.
Publicado: (2021)

Vismodegib in Locally Advanced Basal Cell Carcinoma in Slovenia
por: Mesti, Tanja, et al.
Publicado: (2022)

Targeted Therapy for Advanced Basal-Cell Carcinoma: Vismodegib and Beyond
por: Cowey, C. Lance
Publicado: (2013)

Investigational agents in metastatic basal cell carcinoma: focus on vismodegib
por: Batty, Nicolas, et al.
Publicado: (2012)

Basal cell carcinoma: multimodal treatment and the role of neoadjuvant vismodegib
por: Martins, Pedro Carvalho, et al.
Publicado: (2019)

18-FDG PET/CT assessment of basal cell carcinoma with vismodegib
por: Thacker, Curtis A, et al.
Publicado: (2012)

Profile of vismodegib and its potential in the treatment of advanced basal cell carcinoma
por: Macha, Muzafar A, et al.
Publicado: (2013)

Vismodegib: A smoothened inhibitor for the treatment of advanced basal cell carcinoma
por: Aditya, Suruchi, et al.
Publicado: (2013)

Rapid response to vismodegib in a patient with advanced basal cell carcinoma
por: Vornicova, Olga, et al.
Publicado: (2015)

Combination Trimodality Therapy Using Vismodegib for Basal Cell Carcinoma of the Face
por: Block, Alec M., et al.
Publicado: (2015)

Granulation tissue masquerading as basal cell carcinoma after treatment with vismodegib
por: Miedema, Jayson, et al.
Publicado: (2017)

Vismodegib and orbital excision for treating locally advanced basal cell carcinoma
por: Hogarty, Daniel T, et al.
Publicado: (2018)

Vismodegib treatment in advanced basal cell carcinomas: Real‐life experience
por: Villani, Alessia, et al.
Publicado: (2021)

The Correlation between Proliferative Immunohistochemical Markers and Papillary Thyroid Carcinoma Aggressiveness
por: Sheikh-Ahmad, Mohammad, et al.
Publicado: (2023)

Vismodegib-resistant basal cell carcinomas in basal cell nevus syndrome: Clinical approach and genetic analysis
por: Sinx, Kelly A.E., et al.
Publicado: (2018)

Activation of AMPK sensitizes medulloblastoma to Vismodegib and overcomes Vismodegib‐resistance
por: Gampala, Silpa, et al.
Publicado: (2021)

Giant morphea-form basal cell carcinoma of the umbilicus: Successful debulking with vismodegib
por: Orduz Robledo, Mariana, et al.
Publicado: (2018)

A Non-Interventional Study on Vismodegib for Basal Cell Carcinoma in Swedish Patients
por: Bendsöe, Niels, et al.
Publicado: (2023)

Orbital Lymphatic-Venous Malformation Accompanied by an Intraocular Vascular Malformation: A Rare Case Study
por: Shouchane-Blum, Karny, et al.
Publicado: (2021)

Characterization of Diabetic Retinopathy in Two Mouse Models and Response to a Single Injection of Anti-Vascular Endothelial Growth Factor
por: Azrad-Leibovich, Tamar, et al.
Publicado: (2022)

Safety and efficacy of vismodegib in patients aged ≥65 years with advanced basal cell carcinoma
por: Chang, Anne Lynn S., et al.
Publicado: (2016)

A Matching-Adjusted Indirect Comparison of Sonidegib and Vismodegib in Advanced Basal Cell Carcinoma
por: Odom, Dawn, et al.
Publicado: (2017)

Frequency and Genomic Aspects of Intrinsic Resistance to Vismodegib in Locally Advanced Basal Cell Carcinoma
por: Yurchenko, Andrey A., et al.
Publicado: (2022)

Non-surgical Management of Locally Advanced Basal Cell Carcinoma of the Upper Extremity With Vismodegib
por: Swisher, Austin R, et al.
Publicado: (2022)

Benefit–risk assessment of sonidegib and vismodegib in the treatment of locally advanced basal cell carcinoma
por: García Ruiz, Antonio J, et al.
Publicado: (2022)

Complete pathologic clearance with vismodegib in advanced basal cell carcinoma of the scalp with cranial invasion
por: Dodson, Joseph, et al.
Publicado: (2022)

Characterization of intractable diarrhea resulting from vismodegib treatment for basal cell nevus syndrome
por: Patel, Ashmi, et al.
Publicado: (2022)

Vismodegib in neoadjuvant treatment of locally advanced basal cell carcinoma: First results of a multicenter, open-label, phase 2 trial (VISMONEO study): Neoadjuvant Vismodegib in Locally Advanced Basal Cell Carcinoma
por: Bertrand, Nicolas, et al.
Publicado: (2021)

The co-occurrence of rare non-ocular phenotypes in patients with inherited retinal degenerations
por: Ehrenberg, Miriam, et al.
Publicado: (2019)

Genetic Alteration Analysis of IDH1, IDH2, CDKN2A, MYB and MYBL1 in Pediatric Low-Grade Gliomas
por: Barinfeld, Orit, et al.
Publicado: (2022)

Vismodegib: First-in-Class Hedgehog Pathway Inhibitor for Metastatic or Locally Advanced Basal Cell Carcinoma
por: Nix, Nancy M., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_b9jkuukuda0r3a7epd8l25nbl7